Prenatal Diagnosis of PPP2R1A-Related Neurodevelopmental Disorders Using Whole Exome Sequencing: Clinical Report and Review of Literature

Genes (Basel). 2023 Jan 2;14(1):126. doi: 10.3390/genes14010126.

Abstract

PPP2R1A-related neurodevelopmental disorder (NDD) is expressed with autosomal dominant inheritance and is typically caused by a pathogenic de novo PPP2R1A mutation. It is characterized by the predominant features of hypotonia, developmental delay, moderate-to-severe intellectual disability, agenesis of corpus callosum (ACC), ventriculomegaly, and dysmorphic features; however, none of these anomalies have been diagnosed prenatally. We report on the prenatal diagnosis of PPP2R1A-related NDD in two fetuses by whole exome sequencing. Fetus 1 had partial ACC and severe lateral ventriculomegaly; the pathogenic heterozygous c.544C > T (p. Arg182Trp) de novo missense variant in PPP2R1A was detected. Fetus 2 had severe enlargement of the lateral and third ventricles and macrocephaly; they showed a heterozygous likely pathogenic mutation in PPP2R1A gene (c.547C > T, p. Arg183Trp). Both variants were de novo. This was the first study to use trio WES to prenatally analyze fetuses with PPP2R1A variants. Prenatal diagnosis will not only expand the fetal phenotype of this rare genetic condition but also allow for an appropriate counseling of prospective parents regarding pregnancy outcomes.

Keywords: PPP2R1A; agenesis of corpus callosum (ACC); macrocephaly; neurodevelopmental disorder (NDD); prenatal diagnosis; whole-exome sequencing (WES).

Publication types

  • Review
  • Case Reports
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Exome Sequencing
  • Female
  • Humans
  • Hydrocephalus*
  • Nervous System Malformations*
  • Neurodevelopmental Disorders* / diagnosis
  • Neurodevelopmental Disorders* / genetics
  • Pregnancy
  • Prenatal Diagnosis
  • Prospective Studies
  • Protein Phosphatase 2 / genetics
  • Transcription Factors

Substances

  • Transcription Factors
  • PPP2R1A protein, human
  • Protein Phosphatase 2

Grants and funding

This research was funded by the Project of Guangzhou Science and Technology (202102020191, 202201020604, 20231A011030).